
doi: 10.1136/bmj.a1110
pmid: 18755763
#### Summary points Antituberculosis drug resistance is increasing both in the United Kingdom and internationally.1 2 It has come to greater public attention with the emergence of extensively drug resistant tuberculosis (box 1) in South Africa, where an outbreak proved rapidly fatal among people with advanced HIV infection.3 In this article we review recent global and UK trends in drug resistant tuberculosis and summarise its diagnosis, treatment, and control. Few data are available from randomised controlled trials to guide treatment of drug resistant tuberculosis, and none for multidrug resistant tuberculosis; this review is based primarily on data from observational epidemiological studies and on national and international guidelines. #### Box 1 Definitions relating to tuberculosis and drug resistance
Adult, Bacteriological Techniques, Risk Factors, Practice Guidelines as Topic, Tuberculosis, Multidrug-Resistant, Antitubercular Agents, Humans, Mycobacterium tuberculosis
Adult, Bacteriological Techniques, Risk Factors, Practice Guidelines as Topic, Tuberculosis, Multidrug-Resistant, Antitubercular Agents, Humans, Mycobacterium tuberculosis
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 16 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
